These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 1942307

  • 21. Oxalate crystallization in the kidney in the presence of hyperuricemia.
    Noda S, Hayashi K, Eto K.
    Scanning Microsc; 1989 Sep; 3(3):829-35; discussion 835-6. PubMed ID: 2617264
    [Abstract] [Full Text] [Related]

  • 22. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S, Menon M.
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [Abstract] [Full Text] [Related]

  • 23. Etiology of experimental calcium oxalate monohydrate nephrolithiasis in rats.
    de Bruijn WC, Boevé ER, van Run PR, van Miert PP, Romijn JC, Verkoelen CF, Cao LC, Schröder FH.
    Scanning Microsc; 1994 Jul; 8(3):541-9; discussion 549-50. PubMed ID: 7747156
    [Abstract] [Full Text] [Related]

  • 24. An animal model of calcium oxalate urolithiasis based on a cyclooxygenase 2 selective inhibitor.
    Jeong BC, Park MY, Kwak C, Kim BS, Kim JI, Kim HH.
    Urol Res; 2005 Dec; 33(6):453-9. PubMed ID: 16311770
    [Abstract] [Full Text] [Related]

  • 25. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP, Coe FL, Gillen D, Lingeman JE, Bledsoe S, Worcester EM.
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [Abstract] [Full Text] [Related]

  • 26. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S, Wiessner JH, Hasegawa AT, Hung LY, Mandel GS, Mandel NS.
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [Abstract] [Full Text] [Related]

  • 27. Calcium phosphate/calcium oxalate crystal association in urinary stones: implications for heterogeneous nucleation of calcium oxalate.
    Khan SR.
    J Urol; 1997 Jan; 157(1):376-83. PubMed ID: 8976301
    [Abstract] [Full Text] [Related]

  • 28. Renal tubular damage/dysfunction: key to the formation of kidney stones.
    Khan SR.
    Urol Res; 2006 Apr; 34(2):86-91. PubMed ID: 16404622
    [Abstract] [Full Text] [Related]

  • 29. Experimental studies of adhesion and endocytosis of calcium oxalate crystals in renal tubular cells.
    Kohjimoto Y, Ebisuno S, Tamura M, Ohkawa T.
    Int J Urol; 1996 Jan; 3(1 Suppl):S72-5. PubMed ID: 24304031
    [Abstract] [Full Text] [Related]

  • 30. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
    Robertson WG.
    Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
    [Abstract] [Full Text] [Related]

  • 31. A porcine model of calcium oxalate kidney stone disease.
    Mandel NS, Henderson JD, Hung LY, Wille DF, Wiessner JH.
    J Urol; 2004 Mar; 171(3):1301-3. PubMed ID: 14767337
    [Abstract] [Full Text] [Related]

  • 32. PPARγ agonist alleviates calcium oxalate nephrolithiasis by regulating mitochondrial dynamics in renal tubular epithelial cell.
    Liu J, Liu X, Guo L, Liu X, Gao Q, Wang E, Dong Z.
    PLoS One; 2024 Mar; 19(9):e0310947. PubMed ID: 39325731
    [Abstract] [Full Text] [Related]

  • 33. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones.
    Huang HS, Ma MC, Chen CF, Chen J.
    Urology; 2003 Dec; 62(6):1123-8. PubMed ID: 14665375
    [Abstract] [Full Text] [Related]

  • 34. Cell injury associated calcium oxalate crystalluria.
    Hackett RL, Shevock PN, Khan SR.
    J Urol; 1990 Dec; 144(6):1535-8. PubMed ID: 2231959
    [Abstract] [Full Text] [Related]

  • 35. Ultrastructural events in early calcium oxalate crystal formation in rats.
    Dykstra MJ, Hackett RL.
    Kidney Int; 1979 Jun; 15(6):640-50. PubMed ID: 459245
    [Abstract] [Full Text] [Related]

  • 36. Metabolic syndrome contributes to renal injury mediated by hyperoxaluria in a murine model of nephrolithiasis.
    Sáenz-Medina J, Jorge E, Corbacho C, Santos M, Sánchez A, Soblechero P, Virumbrales E, Ramil E, Coronado MJ, Castillón I, Prieto D, Carballido J.
    Urolithiasis; 2018 Apr; 46(2):179-186. PubMed ID: 28405703
    [Abstract] [Full Text] [Related]

  • 37. Novel porcine model for calcium oxalate stone formation.
    Trojan BP, Trojan SJ, Navetta A, Staches B, Sutton B, Filleur S, Nelius T.
    Int Urol Nephrol; 2017 Oct; 49(10):1751-1761. PubMed ID: 28707190
    [Abstract] [Full Text] [Related]

  • 38. Expression of Tamm-Horsfall protein in stone-forming rat models.
    Miyake O, Yoshioka T, Yoshimura K, Honda M, Yamaguchi S, Koide T, Okuyama A.
    Br J Urol; 1998 Jan; 81(1):14-9. PubMed ID: 9467470
    [Abstract] [Full Text] [Related]

  • 39. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M.
    Scand J Urol Nephrol Suppl; 1989 Jan; 119():1-53. PubMed ID: 2669121
    [Abstract] [Full Text] [Related]

  • 40. [Idiopathic calcium oxalate urinary lithiasis: new physiopathological approaches].
    Berland Y.
    Nephrologie; 1999 Jan; 20(7):363-9. PubMed ID: 10642984
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.